Bystander CD4<sup>+</sup> T cells infiltrate human tumors and are phenotypically distinct-Reference-Cited by-同舟云学术

Bystander CD4⁺ T cells infiltrate human tumors and are phenotypically distinct

Published:2022-01-02 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Li Shamin¹^ORCID,Zhuang Summer¹,Heit Antja¹,Koo Si-Lin²³,Tan Aaron C.³,Chow I-Ting⁴,Kwok William W.⁴,Tan Iain Beehuat²³,Tan Daniel S.W.⁵,Simoni Yannick¹⁶^ORCID,Newell Evan W.¹^ORCID

Affiliation:

1. Fred Hutch Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA

2. Department of Anatomical Pathology, Singapore General Hospital, Singapore

3. Division of Medical Oncology, National Cancer Centre Singapore (NCCS), Singapore, Singapore

4. Agency for Science Technology and Research (A*Star), Genome Institute of Singapore (GIS), Singapore, Singapore

5. Benaroya Research Institute, Seattle, Washington, USA

6. Université de Paris, Institut Cochin INSERM U1016, Paris, France

Funder

Fred Hutchinson Cancer Research Center

The Andy Hill Endowment Distinguished Researcher CARE fund to E.W.N

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.2012961

Reference70 articles.

1. Cancer immunoediting: from immunosurveillance to tumor escape

2. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

3. The blockade of immune checkpoints in cancer immunotherapy

4. Adoptive cell transfer as personalized immunotherapy for human cancer

5. An immunogenic personal neoantigen vaccine for patients with melanoma

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4 ⁺ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy;Science Immunology;2024-09-13

2. Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes;Cancer Letters;2024-09

3. Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies;American Society of Clinical Oncology Educational Book;2024-06

4. An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy;Nature Cancer;2024-04-12

5. Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma;Nature Reviews Clinical Oncology;2024-01-08